tiprankstipranks
Advertisement
Advertisement
Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors
PremiumCompany AnnouncementsAmgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors
5d ago
Amgen price target raised to $388 from $343 at Guggenheim
Premium
The Fly
Amgen price target raised to $388 from $343 at Guggenheim
6d ago
Amgen Earnings Call Highlights New Growth Engines
Premium
Company Announcements
Amgen Earnings Call Highlights New Growth Engines
7d ago
Amgen price target raised to $440 from $420 at UBS
PremiumThe FlyAmgen price target raised to $440 from $420 at UBS
11d ago
Amgen price target raised to $452 from $420 at TD Cowen
Premium
The Fly
Amgen price target raised to $452 from $420 at TD Cowen
11d ago
Terence Flynn Reaffirms Hold on Amgen as Strong Q2 Results and 2026 Guidance Boost Outlook, Price Target Raised from $333 to $351
Premium
Ratings
Terence Flynn Reaffirms Hold on Amgen as Strong Q2 Results and 2026 Guidance Boost Outlook, Price Target Raised from $333 to $351
11d ago
Amgen price target raised to $230 from $215 at Baird
PremiumThe FlyAmgen price target raised to $230 from $215 at Baird
11d ago
Amgen price target raised to $384 from $366 at Canaccord
Premium
The Fly
Amgen price target raised to $384 from $366 at Canaccord
11d ago
Amgen price target raised to $450 from $400 at BMO Capital
Premium
The Fly
Amgen price target raised to $450 from $400 at BMO Capital
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100